SC
BIOA

Scotia Capital’s BioAmber Inc. BIOA Stock Holding History

Scotia Capital’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-14,850
Closed -$35K – 765
2017
Q1 		$35K Hold
14,850
– – ﹤0.01% 716
2016
Q4 		$82K Hold
14,850
– – ﹤0.01% 773
2016
Q3 		$60K Hold
14,850
– – ﹤0.01% 760
2016
Q2 		$44K Buy
14,850
+4,065
+38% +$14.8K ﹤0.01% 695
2016
Q1 		$45K Sell
10,785
-4,265
-28% -$17.9K ﹤0.01% 664
2015
Q4 		$78K Hold
15,050
– – ﹤0.01% 776
2015
Q3 		$80K Buy
15,050
+2,600
+21% +$17.2K ﹤0.01% 748
2015
Q2 		$104K Buy
+12,450
New +$114K ﹤0.01% 720

Other funds holding BIOA

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
NIPH
NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RS
Robeco Schweiz Zurich, Switzerland $6.23B AUM 86.54% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Scotia Capital's BIOA Position: Q2 2017 in Review

Scotia Capital sold out of BioAmber Inc. (BIOA) in Q2 2017, closing a stake of 14,850 shares — an estimated $35K sold.

Scotia Capital first reported a position in BIOA in Q2 2015 and held it in 8 quarters. The position peaked at $104K in Q2 2015. 39 funds tracked by Wall St. Rank hold BIOA as of Q2 2017.

  • Scotia Capital reported no remaining BioAmber Inc. position as of Q2 2017 after selling out during the quarter.
  • Scotia Capital sold 14,850 BioAmber Inc. shares in Q2 2017, an estimated $35K.
  • Scotia Capital first reported a position in BioAmber Inc. in Q2 2015 and held it in 8 quarters.
  • Scotia Capital's BioAmber Inc. position peaked at $104K in Q2 2015.
  • 39 funds tracked by Wall St. Rank held BioAmber Inc. as of Q2 2017.

Based on Scotia Capital's 13F filing for Q2 2017, filed 15 Aug 2017.